Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
10/2005
10/27/2005US20050240026 3-step synthesis of pyrazolotriazole couplers and coupler intermediates
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239899 Beta-secretase inhibitors
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239855 For therapy of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/27/2005US20050239808 Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur
10/27/2005US20050239655 3-heterocyclyl substituted benzoic acid derivatives
10/27/2005US20050239054 Drug screening compounds having esterified phosphonate or carboxyl groups with novel enzyme GS-7340 Ester Hydrolase and identifying the compound as a suitable prodrug by the formation of a phosphonic acid or carboxylic acid; candidate compounds
10/27/2005US20050238909 Luminescent spiro-dimer and organic light-emitting device comprising the same
10/27/2005DE102004016845A1 Phenylthioessigsäure-Derivate und ihre Verwendung Phenylthioacetic acid derivatives and their use
10/27/2005CA2562244A1 Cyclic compounds
10/26/2005EP1589012A2 N-alkylheteroaryl secondary para-phenyldiamine, dyeing composition containing the same, process for making it and uses thereof
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005EP0835245B1 Substituted n-methylenethioureas as pesticides
10/26/2005CN1688553A Chemical process
10/26/2005CN1688527A Fused benzene derivative and use
10/26/2005CN1688315A Use of selective COX-2 inhibitors for the treatment of urinary incontinence
10/26/2005CN1224616C Processes for preparing pesticidal intermediates
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005US6958403 sulfonation of 4,5-dihydro-3-(trifluoromethyl) 1H-pyrazole derivative with chlorosulfonic acid; salt formation of intermediate with sodium hydroxide; optical resolution
10/25/2005US6958356 Guanidine mimics factor Xa inhibitors
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958339 Pyrazole derivative
10/25/2005US6958333 N'-(isoindolino[3,2-b]perhydro-1,3-oxazin-5-on-9-yl)-N-(pyridin-2-yl) urea, for example; cyclin-dependent kinase inhibitors; colon cancer treatment
10/20/2005WO2005097912A1 Azo compound, ink composition, and colored object
10/20/2005WO2005097784A1 Phenylthioacetic acid derivatives and use thereof
10/20/2005WO2005097754A1 Herbicidal 3-amino-2-thiomethyl benzoyl pyrazoles
10/20/2005WO2005097713A1 Fluoridation method
10/20/2005US20050234239 Method of forming a carbon-carbon or carbon-heteroatom linkage
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234111 D-homo-17-chlor-16(17)-ene steroids
10/20/2005US20050234065 Dipeptidyl peptidase-IV inhibitors
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234055 Pyrazole derivative
10/20/2005US20050234020 e.g. 3'-(1-Cyclohexyl-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)-2'-hydroxy-biphenyl-3- carboxylic acid; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia
10/20/2005CA2562140A1 Phenylthioacetic acid derivatives and use thereof
10/20/2005CA2561953A1 Herbicidal 3-amino-2-thiomethyl benzoyl pyrazoles
10/19/2005EP1586572A1 Fused pyrazolyls as anti-cancer drugs
10/19/2005EP1585827A2 Modulation of protein functionalities
10/19/2005EP1585743A1 2-(1h-indazol-6-ylamino)- benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases
10/19/2005EP1585734A2 Anti-inflammatory medicaments
10/19/2005EP1585733A1 Heterocyclic ppar modulators
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005CN1684944A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/19/2005CN1223348C N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines
10/18/2005US6956053 Mixtures of gastric juice secretion antagonist and proton pump inhibitors used for prophylaxis of eating disorders; cyclization
10/18/2005US6956052 treatment of cancer and inflammation-associated disorders, such as arthritis; for example,1-[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
10/18/2005US6956036 6-hydroxy-indazole derivatives for treating glaucoma
10/18/2005CA2307581C Heterocyclic compounds having nos inhibiting action
10/13/2005WO2005095523A1 Monoazo/iron complex compound, charge control agent comprising the same, and toner
10/13/2005WO2005095387A1 Tricyclic pyrazole kinase inhibitors
10/13/2005WO2005095353A1 Tetrahydro-indazole cannabinoid modulators
10/13/2005WO2005095352A1 Process for producing 5-hydroxy-4-thiomethylpyrazole compound
10/13/2005WO2005095351A1 N1 - ((pyrazol-1-ymethyl) -2-methylphenyl)- phatalamide derivatives and related compounds insecticides
10/13/2005WO2005095350A1 Pyrazole compounds and uses related thereto
10/13/2005WO2005095349A1 Crystalline pyrazole derivative
10/13/2005WO2005095348A2 Pyrazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005095330A1 Novel dichloropropene derivatives
10/13/2005WO2005094823A1 Flt-3 INHIBITOR
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005WO2005070910A3 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
10/13/2005WO2005021536A3 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
10/13/2005US20050228034 treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease; for treating, ameliorating or preventing a CB1 receptor inverse-agonist mediated appetite related obesity related or metabolism related syndrome, disorder or disease
10/13/2005US20050228015 Substituted heteroaryl- and phenylsulfamoyl compounds
10/13/2005US20050228000 of the coagulation cascade or contact activation system: thrombin, factor Xa, factor XIa, factor IXa, factor VIIa or plasma kallikrein; e.g. -(6-carbamimidoyl-1H-indol-3-ylmethyl)-4-methoxy-biphenyl-2-carboxylic acid; anticoagulant, antiinflammatory agent
10/13/2005US20050227987 11beta-hydroxysteroid dehydrogenase inhibitors
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227299 Fluorescent dyes (AIDA) for solid phase and solution phase screening
10/13/2005CA2561441A1 Pyrazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005CA2561305A1 Tetrahydro-indazole cannabinoid modulators
10/13/2005CA2560936A1 Process for producing 5-hydroxy-4-thiomethylpyrazole compound
10/13/2005CA2560691A1 Tricyclic pyrazole kinase inhibitors
10/13/2005CA2559945A1 Pyrazole compounds and uses related thereto
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005EP1583746A1 A pyrazole derivative as ppar modulator
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1224173B1 Pyrazole derivatives as cannabinoid receptor antagonists
10/12/2005EP1177188B1 Pyrazole carboxamides useful for the treatment of obesity and other disorders
10/12/2005CN1681794A Preventive and/or therapeutic drugs for inflammatory intestinal diseases
10/12/2005CN1681793A Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681494A 4-(3, 5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of I.A. HIV
10/12/2005CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives
10/12/2005CN1680334A Fused pyrazolyls
10/12/2005CN1680333A Anti-virus pyrazole derivatives
10/12/2005CN1680274A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1222514C Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms
10/12/2005CN1222513C Siliver halide color photographic material, phenidone compounds used therefor, and process for preparing the same
10/12/2005CN1222511C I-aryl-or-I-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-b ligands
10/12/2005CN1222374C Extrusion die
10/11/2005US6953860 Process for preparing 1,5-diaryl-3-substituted pyrazoles
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092887A1 Compounds for the treatment of diseases
10/06/2005WO2005092863A1 4-carbox pyrazole derivates useful as anti-viral agents
10/06/2005WO2005092845A1 Substituted heteroaryl- and phenylsulfamoyl compounds
1 ... 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 ... 256